COMMUNIQUÉS West-GlobeNewswire

Wildflower Brands Inc. Featured in Exclusive NetworkNewsWire Broadcast

06/05/2019 - 14:45

NEW YORK, May 06, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF), a public cannabis company developing and designing brands that focus on plant-based wellness and health [...]

Eyenovia Announces Presentation of Successful Phase 3 Studies at the ASCRS-ASOA Annual Meeting

06/05/2019 - 14:30

Presented Positive Results from Two Phase 3 MicroStat (phenylephrine 2.5% / tropicamide 1% fixed combination ophthalmic solution) Trials NEW YORK, May 06, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) a [...]

Golden Leaf Holdings Brings Jackpot Brand Premium Distillate Products to Oregon Market

06/05/2019 - 14:30

PORTLAND, Ore., May 06, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis company built around recognized brands for the wellness and recreational [...]

Equillium Expands Scientific and Clinical Advisory Team

06/05/2019 - 14:30

LA JOLLA, Calif., May 06, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and [...]

Data Presented at the 2019 American Urological Association (AUA) Annual Meeting Showcases Potential for Progenics’ PyL Imaging Agent

06/05/2019 - 14:30

-Phase 2/3 OSPREY Data Demonstrates PyL’s High Specificity and Sensitivity in Detecting Prostate Cancer- -Data Generated Under PyL Research Access Program Supports Potential of PyL to Detect Disease in Biochemical [...]

Hemispherx Links Stanford’s ME/CFS Diagnostic to a Potential Path Forward for Ampligen Commercialization

06/05/2019 - 14:30

OCALA, Fla., May 06, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma Inc., (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and [...]

Resverlogix Announces Publication on Apabetalone in High-Impact American Journal of Respiratory and Critical Care Medicine (AJRCCM)

06/05/2019 - 14:30

Multinational Research Collaboration Advances Apabetalone Towards Phase 2 Clinical Trial for PAH Patients CALGARY, Alberta, May 06, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) [...]

Transactions under Novozymes’ stock buyback program

06/05/2019 - 14:20

Please read the full announcement in the attached PDF Attachment 2019_11_Stock_Buybackprogram_EN

CorMedix Inc. to Report First Quarter 2019 Financial Results and Provide a Corporate Update on May 13

06/05/2019 - 14:15

BERKELEY HEIGHTS, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment [...]

Catalyst Pharmaceuticals to Hold First Quarter Financial Results Conference Call and Webcast on Monday, May 13th, 2019

06/05/2019 - 14:03

CORAL GABLES, Fla., May 06, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]

VBL Therapeutics to Report First Quarter 2019 Financial Results on May 15

06/05/2019 - 14:00

TEL AVIV, Israel, May 06, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Foamix Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2019

06/05/2019 - 14:00

REHOVOT, Israel, and BRIDGEWATER, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), (“Foamix”), clinical stage specialty pharmaceutical company focused on developing and commercializing [...]

PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Its Fourth Quarter and Fiscal Year End Financial Results and Declares Its $0.27 Per Share Dividend

06/05/2019 - 14:00

DELRAY BEACH, Fla., May 06, 2019 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the fiscal year ended March 31, 2019. Net sales for the quarter ended March 31, 2019 [...]

Progressive Care Inc. and Frostime, LLC Launch Cold Chain Integrity Pilot Program

06/05/2019 - 14:00

MIAMI, May 06, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has launched a cold chain integrity pilot program with [...]

electroCore Selected for Innovation and Technology Payment Program Through NHS England

06/05/2019 - 14:00

gammaCore™ chosen by NHS England to be funded by the Innovation and Technology Payment Program (ITP) for the period of April 2019 to April 2020 to support adoption in the U.K. LONDON and BASKING RIDGE, N.J., May 06, [...]

Alder BioPharmaceuticals® Presents New Data Demonstrating Consistent, Early and Robust Prevention with Eptinezumab for Episodic and Chronic Migraine across Four Clinical Trials

06/05/2019 - 14:00

Data presented at the 2019 American Academy of Neurology (AAN) meeting demonstrate more than 50% of patients achieved rapid onset of migraine prevention with eptinezumab on Day 1 across four clinical trials BOTHELL, [...]

ContraVir Pharmaceuticals Receives Positive Nasdaq Listing Decision

06/05/2019 - 14:00

EDISON, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (Nasdaq: CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from [...]

GBT Announces New Employment Inducement Grants

06/05/2019 - 14:00

SOUTH SAN FRANCISCO, Calif., May 06, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on May 1, 2019, the compensation committee of GBT’s board of directors granted nine [...]

Krystal Biotech Reports First Quarter 2019 Financial Results and Provides Corporate Update

06/05/2019 - 14:00

EMA grants PRIME eligibility for KB103 (bercolagene telserpavec) to treat dystrophic epidermolysis bullosa Krystal Biotech announces five presentations of clinical and preclinical data at the Society for Investigative [...]